Corebridge Financial’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,995
Closed -$183K 242
2025
Q1
$183K Sell
4,995
-75
-1% -$2.58K ﹤0.01% 2126
2024
Q4
$155K Sell
5,070
-382
-7% -$12.7K ﹤0.01% 2320
2024
Q3
$205K Sell
5,452
-1,335
-20% -$51.5K ﹤0.01% 2216
2024
Q2
$269K Buy
+6,787
New +$220K ﹤0.01% 2019

Other funds holding ATEX

Corebridge Financial's ATEX Position: Q2 2025 in Review

Corebridge Financial sold out of Anterix (ATEX) in Q2 2025, closing a stake of 4,995 shares — an estimated $183K sold.

Corebridge Financial first reported a position in ATEX in Q2 2024 and held it in 4 quarters. The position peaked at $269K in Q2 2024. 111 funds tracked by Wall St. Rank hold ATEX as of Q2 2025.

  • Corebridge Financial reported no remaining Anterix position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 4,995 Anterix shares in Q2 2025, an estimated $183K.
  • Corebridge Financial first reported a position in Anterix in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Anterix position peaked at $269K in Q2 2024.
  • 111 funds tracked by Wall St. Rank held Anterix as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.